BRCA2 and ovarian carcinoma: To the best of our knowledge, only one patient with BRCA2 constitutional mosaicism has been described in the literature [34]; however, although mosaicism for BRCA1/2 mutations seems to be rare, this and the mentioned study demonstrate that low-level mosaic mutations can contribute to the etiology of breast and ovarian cancer susceptibility.